HER2 Mutant Non-small Cell Lung Cancer
4 clinical trials · Condition
◉ Watch HER2 Mutant Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC (NCT05246514) | AstraZeneca | 2022-07-13 |
| A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2 (NCT05411276) | Beijing Chest Hospital | 2022-06-30 |
| Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer (NCT01827267) | Puma Biotechnology, Inc. | 2013-07-01 |
Track HER2 Mutant Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.